# FDA Inspection 1250905 - Haider Afzal, M.D. - October 04, 2024

Source: https://www.keypedia.com/records/fda_inspections/haider-afzal-md/c8a59d7f-73ab-4cdb-b8a4-95d91ec0b74b
Source feed: FDA_Inspections

> FDA Inspection 1250905 for Haider Afzal, M.D. on October 04, 2024. Classification: Voluntary Action Indicated (VAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1250905
- Company Name: Haider Afzal, M.D.
- Inspection Date: 2024-10-04
- Classification: Voluntary Action Indicated (VAI)
- Project Area: Bioresearch Monitoring: Human Drugs
- Product Type: Human Drugs
- Office Name: Dallas District Office

## Related Documents

- [FDA Inspection 1250905 - 2024-10-04](https://www.keypedia.com/records/fda_inspections/haider-afzal-md/68293ad5-c16e-4a56-b34b-774c0f67ce28)

Company: https://www.keypedia.com/companies/haider-afzal-md/6809bf21-85a2-40d7-8fed-72f4443f9527

Office: https://www.keypedia.com/offices/dallas-district-office/2d1ee9ae-c44c-4494-8186-a920a69b98f9